Hematopoietic Stem Cell Transplantation in Thalassemia and Sickle Cell Disease. Unicenter Experience in a Multi-Ethnic Population.

Hematopoietic stem cell transplantation (HSCT) still remains the only definitive cure currently available for patients with thalassemia and sickle cell anemia. Results of transplant in thalassemia and in sickle cell anemia have steadily improved over the last two decades due to improvements in preve...

Descripción completa

Detalles Bibliográficos
Autores principales: Marziali, Marco, Isgrò, Antonella, Gaziev, Javid, Lucarelli, Guido
Formato: Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2009
Materias:
How I Treat
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033167/
https://www.ncbi.nlm.nih.gov/pubmed/21415995
http://dx.doi.org/10.4084/MJHID.2009.027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033167/
https://www.ncbi.nlm.nih.gov/pubmed/21415995
http://dx.doi.org/10.4084/MJHID.2009.027

Ejemplares similares